Trastuzumab-NH-PEG8-DBCO

Trastuzumab-NH-PEG8-DBCO is an Anti-Her2 human monoclonal antibody (Trastuzumab) conjugated with NH2-PEG8-DBCO on antibody Fc portion site-specific on Q295 by microbial transglutaminase (mTG). The DAR of trastuzumab-NH-PEG8-DBCO is n >1.5. 98% of antibody is conjugated. This product is used for research only. It can be used as conjugation with any azido chemical compounds in click chemistry.

Product Details
Species Reactivity	Human
Host/Isotype	Cell culture/ IgG1
Class	Monoclonal
Type	Antibody-linker conjugate
Immunogen	Human Her2
DAR (Drug to Antibody Ratio)	>1.5, >98% Ab is conjugated
Clone	Trastuzumab biosimilar
Conjugate	Trastuzumab conjugated with NH2-PEG8-DBCO
Purity	>98%
Molecular Weight	~150kDa
Protein Concentration	2 mg/ml
Formulation	Lyophilized
Storage Condition	4°C for short time, -20°C or -80°C for long time.
Storage Buffer	50 mM Sodium Phosphate, 2 mM EDTA, 6% Trehalose, pH7.0